China National Pharmaceutical Group submitted an application for the listing of the new crown vaccine

, deputy general manager of China National Pharmaceutical Group Co., Ltd., said China National Pharmaceutical Group has submitted a new crown vaccine listing application to the State Drug Administration.Earlier, Liu Jingxuan, party secretary and chairman of China National Pharmaceutical Group Co., Ltd., has publicly stated that the new crown vaccine developed by China National Pharmaceutical Group has been vaccinated by nearly one million people in emergency use, and there is currently no serious adverse reaction. None of the people who worked and studied in more than 150 countries around the world after vaccination were infected.On July 22 this year, China officially launched the emergency use of the new crown vaccine. The Vaccine Management Law clearly stipulates that in the event of a particularly serious public health event, the Application for Emergency Use of Vaccines shall be submitted by the National Health and Health Commission, and the Experts of the State Drug Administration shall demonstrate and agree that the National Health and Health Commission shall make emergency use of the vaccine within a certain scope and within a certain time limit. The aim is to establish an immune barrier in the special population such as medical personnel, epidemic prevention personnel, border control personnel and basic operators of the city, and the operation of the whole city will be stable. (Sina Pharmaceutical News)